Einrichtungen, die zum Universitätsklinikum Erlangen gehören

Immortalised murine R349P desmin knock-in myotubes exhibit a reduced proton leak and decreased ADP/ATP translocase levels in purified mitochondria (2024) Berwanger C, Terres D, Pesta D, Eggers B, Marcus K, Wittig I, Wiesner RJ, et al. Journal article Toward designing human intervention studies to prevent osteoarthritis after knee injury: A report from an interdisciplinary OARSI 2023 workshop (2024) Whittaker JL, Kalsoum R, Bilzon J, Conaghan PG, Crossley K, Dodge GR, Getgood A, et al. Journal article COVID-19 in Systemic Lupus Erythematosus patients treated with belimumab: a retrospective clinical study (2024) Wu Y, Li Y, Wu T, Huang D, Wu J, Zhang W, Jiang X, et al. Journal article IL-1 Inhibitors in the Treatment of Familial Mediterranean Fever: Treatment Indications and Clinical Features in a Large Real-World Cohort (2024) Yalcin-Mutlu M, Icacan OC, Yildirim F, Temiz SA, Fagni F, Schett G, Tascilar K, et al. Journal article Long-Term Experience of Arterio-Venous Fistula Surgery in Children on Hemodialysis (2024) Almási-Sperling V, Gall C, Haney B, Latzel N, Knieling F, Hilger A, Regensburger A, et al. Journal article Non-kin caregivers of terminally ill people: Contributions, experiences, and needs: A protocol for a mixed-methods study (2024) Heckel M, Herbst FA Journal article The Multifaceted Functionality of Plasmacytoid Dendritic Cells in Gastrointestinal Cancers: A Potential Therapeutic Target? (2024) Hansen F, David P, Weber G Journal article, Review article Analysis of CFTR mRNA and Protein in Peripheral Blood Mononuclear Cells via Quantitative Real-Time PCR and Western Blot (2024) Schnell A, Tamm S, Hedtfeld S, Rodriguez Gonzalez C, Hörning A, Lachmann N, Stanke F, et al. Journal article The Immune Checkpoint BTLA in Oral Cancer: Expression Analysis and Its Correlation to Other Immune Modulators (2024) Ries J, Trumet L, Hahn A, Kunater L, Lutz R, Geppert CI, Kesting MR, Weber M Journal article In Vitro Assessment of 177Lu-Labeled Trastuzumab-Targeted Mesoporous Carbon@Silica Nanostructure for the Treatment of HER2-Positive Breast Cancer (2024) Tunçel A, Maschauer S, Prante O, Yurt F Journal article